SJ

Savita Juneja

Active Director Director DIN 10854771
DIN 10854771 First appointment Dec 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value •••• Premium profile

About Savita Juneja

Data last updated:

Savita Juneja is a Director at Ayurinstinct Healthcare Private Limited (since 2025). The company operates in Healthcare. Ayurinstinct Healthcare Private Limited reported revenue of ₹1.03 Cr (FY 2024).

DIN 10854771
Primary Designation Director
Industry Healthcare
First Appointment 15 Dec 2025
Largest company Ayurinstinct Healthcare Private Limited · ₹1.03 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Dec 2025₹1.03 Cr (FY 2024)Active

Board colleagues of Savita Juneja

NameDINCompanyDesignation
Piyush Juneja08758129Ayurinstinct Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ayurinstinct Healthcare Private Limited
Premium access

Shareholding and investment profile for Savita Juneja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Savita Juneja

Savita Juneja currently holds 1 directorship: Ayurinstinct Healthcare Private Limited (Director, since 15 Dec 2025, revenue ₹1.03 Cr (FY 2024)).

Savita Juneja was first appointed on 15 Dec 2025 as Director at Ayurinstinct Healthcare Private Limited.

The current boards of Savita Juneja's companies include Piyush Juneja (Ayurinstinct Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available